Evidence map›Paper›PMID 35320496›Full record

ArticleInflammopharmacology2022

Pharmacological evaluation of anti-arthritic potential of terpinen-4-ol using in vitro and in vivo assays.

Sania Aslam, Waqas Younis, Muhammad Nasir Hayat Malik, Shah Jahan, Alamgeer, Ambreen Malik Uttra, Muhammad Usman Munir, Muhammad Roman

Abstract read
PubMed Publisher
In one paragraph

Article in Inflammopharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
6.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Phytochemicals as Immunomodulatory Agents in Melanoma.International journal of molecular sciences · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 3 countries.

Sania AslamDepartment of Pharmacology, Faculty of Pharmacy, The University of Lahore, Lahore, Pakistan.
Waqas YounisDepartment of Pharmacology, Faculty of Pharmacy, The University of Lahore, Lahore, Pakistan. wy216@njms.rutgers.edu.ORCID http://orcid.org/0000-0001-8530-9573
Muhammad Nasir Hayat MalikDepartment of Pharmacology, Faculty of Pharmacy, The University of Lahore, Lahore, Pakistan.
Shah JahanDepartment of Immunology, University of Health Sciences, Lahore, Pakistan.
AlamgeerUniversity College of Pharmacy, University of the Punjab, Lahore, Pakistan.
Ambreen Malik UttraCollege of Pharmacy, University of Sargodha, Sargodha, Pakistan.
Muhammad Usman MunirDepartment of Pharmaceutical Chemistry, College of Pharmacy, Jouf University, Sakaka, 72388, Aljouf, Saudi Arabia.
Muhammad RomanDepartment of Immunology, University of Health Sciences, Lahore, Pakistan.
University of Health Sciences Lahore · PKUniversity of Lahore · PKJouf University · SARutgers, The State University of New Jersey · USUniversity of Sargodha · PKUniversity of the Punjab · PK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Terpinen 4-ol, a phytochemical is a monoterpene which has been reported for its anti-inflammatory effect. Present research was planned to check its effect against arthritis through in vitro and in vivo models. Terpinen 4-ol was evaluated through in-vitro procedures including blocking of protein (BSA and egg albumin) denaturation and human RBC membrane stabilization. In in vivo study, terpinen 4-ol (15, 30 and 60 mg/kg) was evaluated using formaldehyde and CFA arthritic models. Terpinen 4-ol significantly inhibited increase in paw and joint swelling as compared to diseased group. Terpinen 4-ol showed remarkable antioxidant effect (SOD, reducing power) and also improved body weight, haematological, histopathological and radiological parameters in CFA model. Also, moreover, the excess production of IL-1β, TNF-α, IRAK, and NF-kB were noticeably attenuated in all terpinen 4-ol treated rats, however, IL-17 and IL-10 were distinctly increased compared to arthritic control rats in RT-PCR. Also, terpinen 4-ol showed promising antioxidant effect in DPPH assay. Henceforth, it might be concluded that terpinen 4-ol has anti-arthritic effect which can be attributed to the downregulation of pro-inflammatory cytokines.

Indexed as

AntioxidantsArthritis, ExperimentalTerpenesAnimalsCytokinesNF-kappa BRatsAntioxidantsCytokinesNF-kappa BTerpenesterpinenol-4Anti-arthriticAnti-inflammatoryAntioxidantRT-PCRTerpinen-ol

Identifiers

PMID35320496
OpenAlexW4220679195

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.